VIRP — Virbac SA Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapHigh Flyer

Annual income statement for Virbac SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2019 December 31st	R2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	938	934	1,064	1,216	1,247
Cost of Revenue
Gross Profit	620	614	709	790	810
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	840	750	896	1,037	1,063
Operating Profit	98	184	168	180	184
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	77.7	173	159	176	174
Provision for Income Taxes
Net Income After Taxes	54.2	140	115	121	121
Minority Interest
Equity in Affiliates
Net Income Before Extraordinary Items
Net Income	51.5	136	113	122	121
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	51.5	136	113	122	121
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	6.7	9.85	13.5	14.8	14.5
Dividends per Share